These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 9726048)

  • 1. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
    Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
    Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia.
    Basile C; Lomonte C; Vernaglione L; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Cazzato F
    Nephrol Dial Transplant; 2006 Apr; 21(4):968-74. PubMed ID: 16326747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure.
    Tominaga Y; Sato K; Tanaka Y; Numano M; Uchida K; Takagi H
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S42-7. PubMed ID: 8608662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas.
    Kayath MJ; Martin LC; Vieira JG; Roman LM; Nosé-Alberti V
    Eur J Endocrinol; 1998 Jul; 139(1):78-83. PubMed ID: 9703382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands.
    Lomonte C; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
    J Nephrol; 2005; 18(1):92-5. PubMed ID: 15772929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histopathological study of the parathyroid gland in renal hyperparathyroidism].
    Tominaga Y; Takagi H; Suzuki H; Kondo T
    Nihon Geka Gakkai Zasshi; 1985 May; 86(5):630-9. PubMed ID: 4021994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
    J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy pattern of parathyroid parenchymal cells in renal secondary hyperparathyroidism with relapse.
    Tominaga Y; Grimelius L; Falkmer UG; Johansson H; Falkmer S
    Anal Cell Pathol; 1991 Nov; 3(6):325-33. PubMed ID: 1751399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the alpha- and beta-subunits of human chorionic gonadotropin by subsets of parathyroid cells in states of hyperparathyroidism.
    Carlinfante G; Lampugnani R; Azzoni C; Aprile MR; Brandi ML; Bordi C
    J Pathol; 1998 Aug; 185(4):389-93. PubMed ID: 9828837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative localization of parathyroid glands using methylthionine chloride / tetramethylthionine chloride in secondary hyperparathyroidism.
    Bland KI; Tidwell S; von Fraunhofer JA; Morris RR; McCoy MT; Wathen RL
    Surg Gynecol Obstet; 1985 Jan; 160(1):42-8. PubMed ID: 2578072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
    Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
    Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic abnormalities in parathyroid nodules of uremic patients.
    Chudek J; Ritz E; Kovacs G
    Clin Cancer Res; 1998 Jan; 4(1):211-4. PubMed ID: 9516973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
    Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.
    Cañadillas S; Canalejo A; Santamaría R; Rodríguez ME; Estepa JC; Martín-Malo A; Bravo J; Ramos B; Aguilera-Tejero E; Rodríguez M; Almadén Y
    J Am Soc Nephrol; 2005 Jul; 16(7):2190-7. PubMed ID: 15888568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Optical and ultrastructural morphology in hyperparathyroidism during dialysis].
    Schiaffino E; Zogno C; Schmid C; Mangili F; Cantaboni A
    Pathologica; 1992; 84(1092):445-58. PubMed ID: 1491886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructure of human parathyroid cells in health and disease.
    Cinti S; Sbarbati A
    Microsc Res Tech; 1995 Oct; 32(2):164-79. PubMed ID: 8580510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.
    Tokumoto M; Tsuruya K; Fukuda K; Kanai H; Kuroki S; Hirakata H
    Kidney Int; 2002 Oct; 62(4):1196-207. PubMed ID: 12234290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X; Sun B; Zhou F; Hu J; Yu X; Peng T
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oxyphil cell in abnormal parathyroid glands. A study of 114 cases.
    Allen TB; Thorburn KM
    Arch Pathol Lab Med; 1981 Aug; 105(8):421-7. PubMed ID: 6894851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.